It will be interesting to examine the role of PHD3 that we identified in various tissues in the context of chronic metabolic excess and stress, such as obesity and type 2 diabetes; clarifying this point along with the dependency on PHD3 enzymatic activity and isoform specificity can provide a basis for designing more effective therapeutic strategies that target PHD3. Here, EGLN3 is linked to obesity disorder.